Concepedia

Dan Xu

DX

17

Publications

625

Citations

14

H-Index

2012

Active since

Affiliations

China Pharmaceutical University(Current)

State Key Laboratory of Natural Medicine

Central Hospital of Wuhan

Stanford University

Huazhong University of Science and Technology

Dan Xu is an author at China Pharmaceutical University specializing in medicine, pharmacology, and vascular biology.

ORCID

Top concepts

Publications per year

2012–2023

17

Publications

17

Silybin inhibits NLRP3 inflammasome assembly through the NAD <sup>+</sup> /SIRT2 pathway in mice with nonalcoholic fatty liver disease

Bangling Zhang, Dan Xu, Linlin She et al. · The FASEB Journal · 2017 · 111 citations

Pretreatment of Indobufen and Aspirin and their Combinations with Clopidogrel or Ticagrelor Alleviates Inflammasome Mediated Pyroptosis Via Inhibiting NF-κB/NLRP3 Pathway in Ischemic Stroke

Fengyang Li, Dan Xu, Kai Hou et al. · Journal of Neuroimmune Pharmacology · 2021 · 76 citations

, , +12

Silybin ameliorates hepatic lipid accumulation and modulates global metabolism in an NAFLD mouse model

Runbin Sun, Dan Xu, Qingli Wei et al. · Biomedicine & Pharmacotherapy · 2019 · 65 citations · Full text

, , +20

Caspase-11 promotes renal fibrosis by stimulating IL-1β maturation via activating caspase-1

Naijun Miao, Hongyan Xie, Dan Xu et al. · Acta Pharmacologica Sinica · 2018 · 54 citations · Full text

, , +16

Chimeric TK-NOG Mice: A Predictive Model for Cholestatic Human Liver Toxicity

Dan Xu, Manhong Wu, Sachiko Nishimura et al. · Journal of Pharmacology and Experimental Therapeutics · 2014 · 45 citations · Full text

Rows per page

1–5 of 17